Publication | Open Access
LBA38 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study
40
Citations
1
References
2023
Year
Advanced Cervical CancerCervical CancerMedicineCancer ManagementGynecologyCancer TreatmentLba38 PembrolizumabOncologyRadiation OncologyGynecology Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1